Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Small molecule IM boosts hair growth by changing stem cell metabolism.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Upadacitinib improved multiple immune-related conditions in one patient.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

JAK inhibitors are effective treatments for alopecia areata.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

The assay effectively identifies compounds that affect immune cell activation.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Topical immunotherapy is the best treatment for severe alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

JAK inhibitors might help treat alopecia areata.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Improving nerve and immune interactions may help heal chronic wounds.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.